5-[(2-chloro-4-fluoro-5-pyridin-2-ylbenzoyl)amino]-N-[(1-methyltriazol-4-yl)methyl]-1-phenylpyrazole-3-carboxamide
C26H20ClFN8O2 — CID 126962757
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(2-chloro-4-fluoro-5-pyridin-2-ylbenzoyl)amino]-N-[(1-methyltriazol-4-yl)methyl]-1-phenylpyrazole-3-carboxamide
5-[(2-chloro-4-fluoro-5-pyridin-2-ylbenzoyl)amino]-N-[(1-methyltriazol-4-yl)methyl]-1-phenylpyrazole-3-carboxamide (PubChem CID 126962757) has the molecular formula C26H20ClFN8O2 and a molecular weight of 530.95 g/mol. Its IUPAC name is 5-[(2-chloro-4-fluoro-5-pyridin-2-ylbenzoyl)amino]-N-[(1-methyltriazol-4-yl)methyl]-1-phenylpyrazole-3-carboxamide.
Molecular Properties
| Compound Name | 5-[(2-chloro-4-fluoro-5-pyridin-2-ylbenzoyl)amino]-N-[(1-methyltriazol-4-yl)methyl]-1-phenylpyrazole-3-carboxamide |
|---|---|
| PubChem CID | 126962757 |
| Molecular Formula | C26H20ClFN8O2 |
| Molecular Weight | 530.95 g/mol |
| Exact Mass | 530.14 |
| IUPAC Name | 5-[(2-chloro-4-fluoro-5-pyridin-2-ylbenzoyl)amino]-N-[(1-methyltriazol-4-yl)methyl]-1-phenylpyrazole-3-carboxamide |
| SMILES | Cn1cc(CNC(=O)c2cc(NC(=O)c3cc(-c4ccccn4)c(F)cc3Cl)n(-c3ccccc3)n2)nn1 |
| InChI | InChI=1S/C26H20ClFN8O2/c1-35-15-16(32-34-35)14-30-26(38)23-13-24(36(33-23)17-7-3-2-4-8-17)31-25(37)18-11-19(21(28)12-20(18)27)22-9-5-6-10-29-22/h2-13,15H,14H2,1H3,(H,30,38)(H,31,37) |
| InChIKey | ZLARPCIIMFRYQG-UHFFFAOYSA-N |
| XLogP | 4.04 |
| TPSA | 119.62 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 530.95 |
| LogP ≤ 5 | 4.04 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126962757 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.